Issuer disclosure record

$BCRX

Company name unavailable

Transactions involving this ticker in readable 2022 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.

Purchases

Sales

Filers

Reports

Transaction history

Who disclosed trading $BCRX?

Open in trade feed →

purchaseRep. Josh GottheimerNJ-05

$BCRXBioCryst Pharmaceuticals, Inc. (BCRX)

Rep. Josh Gottheimer's filing reports that a joint account purchased · $1,001 – $15,000

View transaction source status →

Traded Aug 11, 2022Notified Sep 6, 2022Filed Sep 16, 202236 days to file

Owner: JointOriginal filing ↗